A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
NCT05184816
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Leptomeningeal Metastases
Interventions
DRUG:
Deferoxamine (DFO)
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]
[object Object]